Clobquin U Cream contains Clobetasol Propionate 0.05% w/w, Salicylic Acid 3% w/w, Lactic Acid 3% w/w, and Urea 10% w/w. This advanced dermatological formulation is designed to help manage hyperkeratotic and inflammatory skin conditions characterized by thickened, scaly, and rough skin. The combination of a potent corticosteroid with keratolytic and moisturizing agents helps reduce inflammation, soften hardened skin, and improve the penetration of active ingredients into affected areas.
Clobetasol Propionate is a potent topical corticosteroid that helps reduce redness, itching, swelling, and inflammation associated with various dermatological disorders. Salicylic Acid acts as a keratolytic agent that helps remove excess scales and dead skin cells, while Lactic Acid supports skin exfoliation and hydration. Urea functions as an effective moisturizing and softening agent that helps restore skin smoothness and improve skin texture. Together, these ingredients provide comprehensive support for the management of difficult-to-treat skin conditions.
The cream is commonly used in the management of psoriasis, chronic eczema, hyperkeratosis, lichenified skin disorders, and other inflammatory dermatological conditions associated with excessive scaling and skin thickening. Its multi-action formulation helps improve skin appearance, reduce discomfort, and support healthier skin texture when used according to medical advice. Regular and appropriate application can help enhance treatment outcomes and improve patient comfort.
With the increasing prevalence of chronic dermatological disorders and the growing demand for specialized skin care treatments, Clobquin U Cream maintains strong relevance in the dermatology segment. Its effective combination of anti-inflammatory, keratolytic, exfoliating, and moisturizing agents contributes to consistent demand among healthcare professionals. The product offers excellent business potential and sustainable growth opportunities for retailers and distributors operating within the dermatology pharmaceutical sector.